Tradestie Institutional Equity Comparison Engine

CGEN vs VCYT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CGEN Overall Edge

CGEN Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Compugen Ltd (CGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical while VCYT counters with relative strength in Options & Structure. Fundamentally, CGEN trades at 12.4x Forward P/E with 41.3% operating margin (+102.1% YoY revenue) versus VCYT at 15.5x Forward P/E and 15.0% operating margin (+15.1% YoY). In options structure, CGEN sits in BREAKDOWN (57th %ile IV; Dealer Gamma Walls on Pro) against VCYT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CGEN
CGEN 12.4x vs VCYT 15.5x Fwd P/E
Growth & Margin Winner CGEN
Op Margin 41.3% vs 15.0% ยท YoY +102.1% vs +15.1%
Momentum & Technical Winner CGEN
1Y +23.2% vs -38.4% ยท 52W Pos 33% vs 6%
Options & Structure Winner VCYT
BREAKDOWN (57th %ile IV) vs BREAKDOWN (9th %ile IV)
CGEN NASDAQ
Compugen Ltd
Biological Products, (No Diagnostic Substances)
$2.02
-0.98% 1D
Market Cap $193.2M
1M Return +2.54%
1Y Return +23.17%
Forward P/E 12.4x
Unified AI Score
47.1 / 100 HOLD
Tech 44.0 Fund 52.0 Flow 54.0 Mom 64.0
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.23
+0.92% 1D
Market Cap $1.9B
1M Return -44.68%
1Y Return -38.42%
Forward P/E 15.5x
Unified AI Score
48.0 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CGEN +23.17% VCYT -38.42% Spread: +61.59 pp (CGEN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CGEN Revenue VCYT Revenue CGEN Op. Margin VCYT Op. Margin Margin Edge
FY2018 $20M $90M -130.5% -24.2% VCYT
FY2019 N/A $120M N/A -12.6% VCYT
FY2020 $0M $120M -1574.8% -30.1% VCYT
FY2021 $10M $220M -584.6% -37.3% VCYT
FY2022 $10M $300M -471.7% -13.9% VCYT
FY2023 $30M $360M -38.8% -23.8% VCYT
FY2024 $30M $450M -53.4% 3.6% VCYT
FY2025 $70M $520M 43.1% 11.2% CGEN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CGEN (8) vs VCYT (2)
Institutional Metric CGEN VCYT Criterion Row Winner
Market Capitalization Scale $193.2M $1.9B Larger Scale VCYT
Trailing P/E Ratio Valuation 5.2x 15.6x Lower Multiple CGEN
Forward P/E Ratio Valuation 12.4x 15.5x Lower Multiple CGEN
Revenue Growth (YoY) Growth +102.1% +15.1% Higher Growth CGEN
Operating Margin (TTM) Profitability 41.3% 15.0% Higher Margin CGEN
Net Profit Margin Profitability 47.9% 21.8% Higher Margin CGEN
Return on Equity (ROE) Capital Efficiency 57.2% 9.4% Higher ROE CGEN
52-Week Range Position Momentum 33% ($1โ€“$3) 6% ($22โ€“$61) Stronger Trend CGEN
Beta / 30D Volatility Risk Regime 1.44ฮฒ ยท 62% Vol 2.98ฮฒ ยท 194% Vol Lower Realized Risk CGEN
Unified Institutional Score Composite Signal 47.1 / 100 (HOLD) 48.0 / 100 (HOLD) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CGEN vs VCYT Buy Guide
CGEN BREAKDOWN
143d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 57th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VCYT BREAKDOWN
100d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CGEN nor VCYT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.